Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$1.030M
Current Assets
2025 Q4
Current Liabilities
2025 Q4
Current Ratio
2025 Q4
2.05%
Total Assets
2025 Q4
Total Liabilities
2025 Q4
Book Value
2025 Q4
-$2.794M
Cash
2025 Q4
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$187.5K

Stock Price

Loading...
Market Cap: $24.578 Million

About Avai Bio Inc

Avai Bio Inc (AVAI) is a pre-revenue technology company that describes itself as specializing in acquiring, creating, and developing artificial intelligence technologies and providing information technology consulting services. The company generated no revenue in either fiscal year ended March 31, 2025 or March 31, 2024. Total operating expenses were $1,532,792 for FY2025, down 28% from $2,117,182 in FY2024, driven primarily by lower employee and contractor compensation included in general and administrative expenses. The company's key disclosed assets include an acquisition called Avant! AI and a Joint Venture and License Agreement with Ainnova Tech Inc. (AINN), described as providing resources in full-stack software development, database management, data integration, project management, and cloud services. The company carries a going concern qualification from its auditors and estimates it needs approximately $10,000,000 in additional capital to fully execute its business plan. Shares trade on the OTC QB marketplace. Principal offices are listed at Sv. Stepono g. 27D-2, LT-01315 Vilnius, Lithuania, per the 10-K filed July 8, 2025.

Revenue model
No revenue generated in FY2025 or FY2024 (fiscal years ended March 31, 2025 and March 31, 2024). The company is pre-revenue and dependent on equity and debt financings to fund operations.
Products and services
Artificial intelligence software described as using unsupervised clustering and proprietary supervised learning techniques; full-stack software development; database management; data integration; project management; cloud services; information technology consulting services. Assets include Avant! AI and a license agreement with Ainnova Tech Inc. (AINN).
Customers and end markets
No customers or end market revenue disclosed in the filing excerpts for FY2025 or FY2024.
Value-chain role
Early-stage AI technology developer and IT consulting services provider, acquiring and licensing AI-related technology assets. Dependent on third-party equity and debt capital to fund operations.
Geographic exposure
Principal executive offices listed in Vilnius, Lithuania, per the 10-K filed July 8, 2025. A USA address is referenced but not specified in the available excerpts.

Source: SEC 10-K, filed 2025-07-08

Industry: Services-Computer Processing & Data Preparation Peers: DecisionPoint Systems, Inc. COMPUTER TASK GROUP INC CSP Inc Research Solutions Inc Glimpse Group Inc International Business Machines Corp PFSWEB INC MicroAlgo Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support